Parling PharmaTech Co., Ltd.

we supply paclitaxel, docetaxel, paclitaxel and docetaxel side chains, imatinib, erlotinib, gefitinib, sunitinib, lapatinib, capatinib, gemcitabine, capecitabine, letrozole, tansolusin, melphalan, dorzolamide, and others.

Activity:

- Manufacturing
- Market Research & Marketing
- Research & Development

Product / Technology type(s) covered:

- API / chemicals

Therapeutic targets:

- Cancer

Markets Covered

a. HeadQuarter: China

b. Continent(s) active: Africa , Asia , North America , Europe

c. Countries active: China

Corporate data:

Number of Employees: 150

Turnover:

Amount:	Year:	Currency:
10000000	2006	US Dollar

Year founded: 1998